Weight change among patients engaged in medication treatment for opioid use disorder: a scoping review

References

• Centers for Disease Control and Prevention. Drug overdose deaths in the U.S. Top 100,000 Annually. 2021. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2021/20211117.htm [accessed 5 May 2023].
   Google Scholar
• Department of Mental Health and Substance Abuse WHO. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva, Switzerland: World Health Organization; 2009.
   Google Scholar
• Abdelaal M, le Roux CW, Docherty NG. Morbidity and mortality associated with obesity. Ann Trans Med. 2017;5:161. doi:10.21037/atm.2017.03.107.
   PubMed Web of Science ®Google Scholar
• Lenz M, Richter T, Mühlhauser I. The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review. Deutsches Ärzteblatt Int. 2009;106:641. doi:10.3238/arztebl.2009.0641.
   PubMed Web of Science ®Google Scholar
• Voon P, Hayashi K, Milloy M, Nguyen P, Wood E, Montaner J, Kerr T. Pain among high-risk patients on methadone maintenance treatment. J Pain. 2015;16:887–94. doi:10.1016/j.jpain.2015.06.003.
   PubMed Web of Science ®Google Scholar
• Hassamal S, Miotto K, Wang T, Saxon AJ. A narrative review: the effects of opioids on sleep disordered breathing in chronic pain patients and methadone maintained patients. Am J Addict. 2016;25:452–65. doi:10.1111/ajad.12424.
   PubMed Web of Science ®Google Scholar
• Fareed A, Byrd‐sellers J, Vayalapalli S, Drexler K, Phillips L. Predictors of diabetes mellitus and abnormal blood glucose in patients receiving opioid maintenance treatment. Am J Addict. 2013;22:411–16. doi:10.1111/j.1521-0391.2013.12043.x.
   PubMed Web of Science ®Google Scholar
• Papadopoulos S, Brennan L. Correlates of weight stigma in adults with overweight and obesity: a systematic literature review. Obesity. 2015;23:1743–60. doi:10.1002/oby.21187.
   PubMed Web of Science ®Google Scholar
• Chen EY, Bocchieri-Ricciardi LE, Munoz D, Fischer S, Katterman S, Roehrig M, Dymek-Valentine M, Alverdy JC, Le Grange D. Depressed mood in class III obesity predicted by weight-related stigma. Obes Surg. 2007;17:669–71. doi:10.1007/s11695-007-9112-4.
   PubMed Web of Science ®Google Scholar
• Achtyes E, Simmons A, Skabeev A, Levy N, Jiang Y, Marcy P, Weiden PJ. Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia. BMC Psychiatry. 2018;18:292. doi:10.1186/s12888-018-1856-y.
   PubMed Web of Science ®Google Scholar
• Mustafa S, Joober R, Lepage M, Iyer S, Shah J, Malla A. Predictors of ‘all-cause discontinuation’ of initial oral antipsychotic medication in first episode psychosis. Schizophr Res. 2018;201:287–93. doi:10.1016/j.schres.2018.04.027.
   PubMed Web of Science ®Google Scholar
• Peters MDJ, Godfrey C, McInerney P, Munn Z, Tricco AC. H. K. Scoping reviews. In: Aromataris E, and Munn Z, editors. JBI manual for evidence synthesis. Joanna Briggs Institute JBI; 2020. https://doi.org/10.46658/JBIMES-20-12
   Google Scholar
• Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MD, Horsley T, Weeks L. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467–73. doi:10.7326/M18-0850.
   PubMed Web of Science ®Google Scholar
• [accessed 2020 February 21]. https://www.cdc.gov/obesity/adult/defining.html.
   Google Scholar
• Parvaresh N, Sabahi AR, Mazhari S, Gilani H. A study of the sexual function, sleep, and weight status of patients after 6 months of methadone maintenance treatment. Addict Health. 2015;7:24–29.
   PubMedGoogle Scholar
• Montazerifar F, Karajibani M, Lashkaripour K, Yosefi M, Dorzadeh H, Dashipour A-R. Dietary intakes of opiate abusers before and during methadone maintenance treatment. Heroin Addict Relat Clin Probl. 2014;16:41–47.
   Web of Science ®Google Scholar
• Montazerifar F, Karajibani M, Lashkaripour K, Yousefi M. Effects of Methadone Maintenance Therapy (MMT) on serum leptin, lipid profile, and anthropometric parameters in opioid addicts. Heroin Addict Relat Clin Probl. 2014;16:9–16.
   Web of Science ®Google Scholar
• Sadek GE, Chiu S, Cernovsky ZZ. Body composition changes associated with methadone treatment. Int J High Risk Behav Addict. 2016;5. doi:10.5812/ijhrba.27587.
   PubMedGoogle Scholar
• Malik E, Rozner L, Adelson M, Schreiber S, Peles E. The relation between changes in vitamin D and Vitamin B12 levels, body mass index and outcome in methadone maintenance treatment patients. J Psychoactive Drugs. 2021;53:55–64. doi:10.1080/02791072.2020.1840680.
   PubMed Web of Science ®Google Scholar
• DeVido J, Connery H, Hill KP. Sleep-disordered breathing in patients with opioid use disorders in long-term maintenance on buprenorphine-naloxone: a case series. J Opioid Manag. 2015;11:363–66. doi:10.5055/jom.2015.0285.
   PubMedGoogle Scholar
• Baykara S, Alban K. The effects of buprenorphine/naloxone maintenance treatment on sexual dysfunction, sleep and weight in opioid use disorder patients. Psychiatry Res. 2019;272:450–53. doi:10.1016/j.psychres.2018.12.153.
   PubMed Web of Science ®Google Scholar
• Varghese ST, Sagar R. Naltrexone-induced weight gain. Ger J Psychiatry. 2006;9:60–61.
   Google Scholar
• Mysels DJ, Vosburg SK, Benga I, Levin FR, Sullivan MA. Course of weight change during naltrexone versus methadone maintenance for opioid-dependent patients. J Opioid Manag. 2011;7:47–53. doi:10.5055/jom.2011.0048.
   PubMedGoogle Scholar
• Reimer J, Verthein U, Karow A, Schäfer I, Naber D, Haasen C. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial. Addiction. 2011;106:1647–55. doi:10.1111/j.1360-0443.2011.03463.x.
   PubMed Web of Science ®Google Scholar
• Peles E, Schreiber S, Hamburger RB, Adelson M. No change of sleep after 6 and 12 months of methadone maintenance treatment. J Addict Med. 2011;5:141–47. doi:10.1097/ADM.0b013e3181e8b6c4.
   PubMed Web of Science ®Google Scholar
• Peles E, Schreiber S, Sason A, Adelson M. Risk factors for weight gain during methadone maintenance treatment. Subst Abuse Rehabil. 2016;37:613–18. doi:10.1080/08897077.2016.1179705.
   Web of Science ®Google Scholar
• Housova J, Wilczek H, Haluzik M, Kremen J, Krizova J, Haluzik M. Adipocyte-derived hormones in heroin addicts: the influence of methadone maintenance treatment. Physiol Res. 2005;54:73–78. doi:10.33549/physiolres.930568.
   PubMed Web of Science ®Google Scholar
• Sweeney MM, Antoine DG, Nanda L, Géniaux H, Lofwall MR, Bigelow GE, Umbricht A. Increases in body mass index and cardiovascular risk factors during methadone maintenance treatment. J Opioid Manag. 2019;15:367–74. doi:10.5055/jom.2018.0526.
   PubMedGoogle Scholar
• Kolarzyk E, Pach D, Wojtowicz B, Szpanowska-Wohn A, Szurkowska M. Nutritional status of the opiate dependent persons after 4 years of methadone maintenance treatment. Przegl Lek. 2005;62:373–77.
   PubMedGoogle Scholar
• Li SS, Ryan L, Neale J. Diet and nutrient intake of people receiving opioid agonist treatment (OAT): implications for recovery. Drugs Alcohol Today. 2016;16:59–71. doi:10.1108/DAT-08-2015-0047.
   Google Scholar
• Fenn JM, Laurent JS, Sigmon SC. Increases in body mass index following initiation of methadone treatment. J Subst Abuse Treat. 2015;51:59–63. doi:10.1016/j.jsat.2014.10.007.
   PubMed Web of Science ®Google Scholar
• Stein M, Binder A, Berg K. Increasing rates of obesity among drug users in the first year of enrollment in a methadone program. 31st Annual Meeting of the Society of General Internal Medicine; 2008; Pittsburgh, Pennsylvania. Journal of General Internal Medicine, 328.
   Google Scholar
• Preston KL, Riley P, Reamer D, Schmittner JP, Epstein DH, Phillips KA Effect of methadone maintenance on body mass index and lipid profile in a cocaine-and heroin-using population. 40th Annual Meeting of the American College of Clinical Pharmacology; 2011. Pittsburgh, Pennsylvania. Journal of Clinical Pharmacology, 1329.
   Google Scholar
• Umbricht A, Schroeder JR, Antoine DG, Tompkins DA, Barnhouser C, Strain EC, Bigelow G. Topiramate effect on weight gain during methadone maintenance. College on Problems of Drug Dependence Scientific Meeting 2015, 2015. Drug and Alcohol Dependence, 2015; e227.
   Google Scholar
• Staub D, Vargo MA, Leveille TL Tackling a weighty issue. In Dr. James West Quality improvement award, National Association of Addiction Treatment Providers National Conference, Apr, 2009. Behav Healthc. 2009: 24–25.
   Google Scholar
• Montazerifar F, Karajibani M, Lashkaripour K. Effect of methadone maintenance therapy on anthropometric indices in opioid dependent patients. Int J High Risk Behav Addict. 2012;1:100. doi:10.5812/ijhrba.4968.
   PubMedGoogle Scholar
• IntHout J, Ioannidis JP, Borm GF, Goeman JJ. Small studies are more heterogeneous than large ones: a meta-meta-analysis. J Clin Epidemiol. 2015;68:860–69. doi:10.1016/j.jclinepi.2015.03.017.
   PubMed Web of Science ®Google Scholar
• GBD Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27. doi:10.1056/NEJMoa1614362.
   PubMed Web of Science ®Google Scholar
• [ accessed 2023 Februray 22]. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022580.
   Google Scholar
• Mauvais-Jarvis F. Sex differences in metabolic homeostasis, diabetes, and obesity. Biol Sex Differ. 2015;6:1–9. doi:10.1186/s13293-015-0033-y.
   PubMed Web of Science ®Google Scholar
• Huhn AS, Berry MS, Dunn KE. Review: sex-based differences in treatment outcomes for persons with opioid use disorder. Am J Addiction. 2019;28:246–61. doi:10.1111/ajad.12921.
   PubMed Web of Science ®Google Scholar
• Evans EA, Goff SL, Upchurch DM, Grella CE. Childhood adversity and mental health comorbidity in men and women with opioid use disorders. Addict Behav. 2020;102. doi:10.1016/j.addbeh.2019.106149.
   Web of Science ®Google Scholar
• Manza P, Kroll D, McPherson KL, Johnson A, Dennis E, Hu L, Tai B, Volkow ND. Sex differences in weight gain during medication-based treatment for opioid use disorder: a meta-analysis and retrospective analysis of clinical trial data. Drug Alcohol Depend. 2022;238:109575. doi:10.1016/j.drugalcdep.2022.109575.
   PubMed Web of Science ®Google Scholar
• Paeratakul S, Lovejoy JC, Ryan DH, Bray GA. The relation of gender, race and socioeconomic status to obesity and obesity comorbidities in a sample of US adults. Int J Obes. 2002;26:1205–10. doi:10.1038/sj.ijo.0802026.
   PubMed Web of Science ®Google Scholar
• Hansen HB, Siegel CE, Case BG, Bertollo DN, DiRocco D, Galanter M. Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City. J Behav Health Serv Res. 2013;40:367–77. doi:10.1007/s11414-013-9341-3.
   PubMed Web of Science ®Google Scholar
• Manhapra A, Quinones L, Rosenheck R. Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the veterans health administration. Drug Alcohol Depend. 2016;160:82–89. doi:10.1016/j.drugalcdep.2015.12.035.
   PubMed Web of Science ®Google Scholar
• Hutfless S, Maruthur NM, Wilson RF, Gudzune KA, Brown R, Lau B, Fawole OA, Chaudhry ZW, Anderson CAM, Segal JB. AHRQ comparative effectiveness reviews. Strategies to prevent weight gain among adults. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013.
   Google Scholar
• Sherman MM, Ungureanu S, Rey JA. Naltrexone/Bupropion ER (Contrave): newly approved treatment option for chronic weight management in obese adults. Pharmacol Ther. 2016;41:164–72. doi:10.1001/jama.2014.732.
   Web of Science ®Google Scholar
• Reed J, Ghodse A. Oral glucose tolerance and hormonal response in heroin-dependent males. Br Med J. 1973;2:582–85. doi:10.1136/bmj.2.5866.582.
   PubMed Web of Science ®Google Scholar
• Passariello N, Giugliano D, Quatraro A, Consoli G, Sgambato S, Torella R, D’Onofrio F. Glucose tolerance and hormonal responses in heroin addicts. A possible role for endogenous opiates in the pathogenesis of non-insulin-dependent diabetes. Metabolism. 1983;32:1163–65. doi:10.1016/0026-0495(83)90065-3.
   PubMed Web of Science ®Google Scholar
• Elman I, Howard M, Borodovsky JT, Mysels D, Rott D, Borsook D, Albanese M. Metabolic and addiction indices in patients on opioid agonist medication-assisted treatment: a comparison of buprenorphine and methadone. Sci Rep. 2020;10:1–12. doi:10.1038/s41598-020-62556-0.
   PubMed Web of Science ®Google Scholar
• Mysels DJ, Sullivan MA. The relationship between opioid and sugar intake: review of evidence and clinical applications. J Opioid Manag. 2010;6:445. doi:10.5055/jom.2010.0043.
   PubMedGoogle Scholar
• Sason A, Adelson M, Herzman-Harari S, Peles E. Knowledge about nutrition, eating habits and weight reduction intervention among methadone maintenance treatment patients. J Subst Abuse Treat. 2018;86:52–59. doi:10.1016/j.jsat.2017.12.008.
   PubMed Web of Science ®Google Scholar
• Spring B, Schneider K, Smith M, Kendzor D, Appelhans B, Hedeker D, Pagoto S. Abuse potential of carbohydrates for overweight carbohydrate cravers. Psychopharmacol (Berl). 2008;197:637–47. doi:10.1007/s00213-008-1085-z.
   PubMed Web of Science ®Google Scholar
• Stanton A. The SAMHSA evaluation of the impact of the DATA waiver program. Summary Report. Rockville, MD: WESTAT: 2006.
   Google Scholar
• Siddiqi A, Brown R, Nguyen QC, Loopstra R, Kawachi I. Cross-national comparison of socioeconomic inequalities in obesity in the United States and Canada. Int J Equity Health. 2015;14:1–10. doi:10.1186/s12939-015-0251-2.
   PubMed Web of Science ®Google Scholar
• Butryn ML, Webb V, Wadden TA. Behavioral treatment of obesity. Psychiatr Clin North Am. 2011;34:841–59. doi:10.1016/j.psc.2011.08.006.
   PubMed Web of Science ®Google Scholar
• Loh C, Meyer JM, Leckband SG. A comprehensive review of behavioral interventions for weight management in schizophrenia. Ann Clin Psychiatry. 2006;18:23–31. doi:10.1080/10401230500464646.
   PubMedGoogle Scholar
• Speyer H, Jakobsen AS, Westergaard C, Nørgaard HCB, Pisinger C, Krogh J, Hjorthøj C, Nordentoft M, Gluud C, Correll CU. Lifestyle interventions for weight management in people with serious mental illness: a systematic review with meta-analysis, trial sequential analysis, and meta-regression analysis exploring the mediators and moderators of treatment effects. Psychother Psychosom. 2019;88:350–62. doi:10.1159/000502293.
   PubMed Web of Science ®Google Scholar
• King L, Gill T, Allender S, Swinburn B. Best practice principles for community-based obesity prevention: development, content and application. Obes Rev. 2011;12:329–38. doi:10.1111/j.1467-789X.2010.00798.x.
   PubMed Web of Science ®Google Scholar
• Schlienz NJ, Huhn AS, Speed TJ, Sweeney MM, Antoine DG. Double jeopardy: a review of weight gain and weight management strategies for psychotropic medication prescribing during methadone maintenance treatment. Int Rev Psychiatry. 2018;30:147–54. doi:10.1080/09540261.2018.1509843.
   PubMed Web of Science ®Google Scholar